Billing and coding for independent clinical labs, anatomic pathology, molecular and genetic labs, toxicology labs, physician office labs and hospital outreach programs.
A laboratory runs on volume. Thousands of claims a month, most of them worth less than a routine office visit, each one carrying a CLIA number, an ordering provider NPI, a diagnosis that has to clear a national coverage edit, and often a modifier that says another laboratory did the work. One missing field does not cost you one test. It repeats on every claim behind it until somebody finds the pattern, and by then the filing window on the oldest batch is already closed.
On this page
Laboratory billing services handle coding, claim submission, denial work and AR for clinical, pathology, molecular and toxicology labs paid under the Medicare Clinical Laboratory Fee Schedule. Work covers CLIA validation, modifier 90 on referred tests and payer medical necessity rules. In a Luxen claim audit, ordering provider NPI was missing or invalid on 9% of lab claims.
Independent clinical laboratories bill the Part B contractor on the CMS-1500 under place of service 81, paid on the Clinical Laboratory Fee Schedule with no Part B deductible and no coinsurance on assigned claims. Physician office laboratories bill under the practice NPI and live or die on whether the CLIA certificate matches the complexity of the test. Hospital outreach programs testing non-patient specimens bill the Part A contractor on bill type 14X, a different form and a different contractor from the one the same building uses for registered outpatients.
Anatomic pathology groups split professional and technical components. Molecular and genetic laboratories work inside the MolDX program, where a test identifier has to be registered before the first claim goes out. Toxicology laboratories run presumptive and definitive testing under per-day code limits, and most of that volume arrives from substance abuse treatment programs. Reference laboratories take send-out work from all of them, and exactly one party gets to bill it.
We bill all six, plus the lines that sit alongside the core chemistry and hematology panel: cytology, specimen collection and travel, and patient balances.
Laboratory revenue leaks the same $40 to $80 several thousand times, in patterns a monthly collections report will never show. These six account for most of what we recover in a first quarter.
| Scenario | Codes | What goes wrong | $ at stake per claim | Luxen audit finding |
|---|---|---|---|---|
| Send-out testing billed as your own work | Modifier 90, any CLFS code | Without modifier 90 and a second CLIA number the claim is returned as unprocessable, not denied, so it never reaches a denial report | $58 median allowed value | Modifier 90 was missing on 12% of referred laboratory claims |
| Second specimen drawn the same day | Modifier 91, 59, XU | The repeat bundles into the first test, or a rerun is billed that the NCCI manual does not allow at all | $24 median allowed value | Repeat test modifier errors appeared on 8% of same-day laboratory claims |
| CLIA certificate does not cover the test run | QW plus every non-waived code | A waived-only lab bills a moderate complexity test, or the CLIA number is absent, and Medicare denies at the certificate level | $63 median allowed value | Laboratory claims rejected for a CLIA number problem carried a $63 median allowed value |
| Diagnosis will not clear a national coverage edit | 80061, 83036, 84443, 85025 | The lab NCD edit software rejects the ICD-10 code the ordering physician supplied, and nobody goes back to the order | 26% of denied dollars | National coverage diagnosis mismatches drove 26% of denied laboratory dollars |
| Molecular test billed without a registered identifier | 81479 and MolDX-covered codes | In a MolDX jurisdiction a claim without the test identifier in loop 2400 is rejected as unprocessable | 41% denial rate | Molecular claims sent without a registered test identifier were denied 41% of the time |
| Hospital specimen billed on the wrong date of service | ADLT and molecular pathology codes | The 14-day rule is applied to a specimen that does not qualify, or ignored on one that does, so the wrong party bills | $38 average shortfall | The average underpaid claim was short by $38 |
Chapter 16 of the Medicare Claims Processing Manual requires independent laboratories to append modifier 90 to every referred service, and returns claims identifiable as referred services without it. The claim needs two CLIA numbers, billing and performing, item 20 marked yes, the purchase price under charges, and item 32 carrying the name, address and NPI of where the test was performed. Referred and non-referred lines go on separate claims, and modifier 90 cannot be appended to code 36415. A referring lab may bill a referred test only if it is part of a rural hospital, is in a wholly owned arrangement, or refers fewer than 30% of the tests it receives in a year.
| Modifier | Means | Laboratory rule |
|---|---|---|
| 90 | Reference (outside) laboratory | Independent labs must use it on all referred services. Claims identifiable as referred without it are returned unprocessable |
| 91 | Repeat clinical diagnostic laboratory test | Medically necessary repeat on the same day only. Not for confirming a result or for a specimen or equipment rerun |
| QW | CLIA waived test | Required so Medicare recognizes the code as waived. 87494QW and 87812QW were added effective January 1, 2026 |
| 59, XE, XP, XS, XU | Distinct procedural service | Bypasses an NCCI edit. XS for different anatomic sites in cytopathology, XU for a second method |
| 26 and TC | Professional and technical component | Anatomic pathology and any test with a split component. Modifier 90 is not used with anatomic pathology services |
| GA, GX, GY, GZ | ABN and liability | GA for a mandatory ABN, GX for a voluntary one, GY for a statutorily excluded test, GZ where no ABN was obtained |
Chapter X of the NCCI Policy Manual is explicit that repeat testing cannot be billed to confirm initial results, or because of a specimen or equipment problem, when one reportable result is all that is required. Modifier 91 is also wrong where a single code already describes a test series, such as glucose tolerance testing. It pairs with QW on a waived test. These decisions belong in the charge build, not the appeal: our certified coding team sets the rules once against your test menu, and denial and AR recovery works the backlog the old rules created. Across 38 client practices, first-pass denial rate fell from 14.2% to 6.1% within 90 days of onboarding.
Under 42 CFR 414.510(a) the date of service for a clinical laboratory or pathology specimen is the date the specimen was collected, not the date the test was run and not the date the result was released. Where collection spans more than one calendar day, the date of service is the date collection ended. Where a specimen sat in storage more than 30 calendar days, the date of service becomes the date it came out of storage.
Section 414.510(b)(2)(i) is the exception every outreach and reference laboratory argues about. The date of service may be the date the test was performed only when all five conditions hold: the treating physician ordered the test at least 14 days after discharge, the specimen was collected during a hospital surgical procedure, collecting it any other way would have been medically inappropriate, the result did not guide treatment during the stay, and the test was reasonable and necessary for treatment of an illness.
For molecular pathology tests, advanced diagnostic laboratory tests, cancer-related protein-based tests and CPT 81490, section 414.510(b)(5) allows the performing laboratory to bill Medicare directly for a specimen collected from a hospital outpatient, rather than billing the hospital. That provision decides whether a high-value molecular claim is your revenue or a line on a hospital invoice, and it is the most common place we find a laboratory billing the wrong party for a year without noticing. These errors do not produce a clean denial. They produce a duplicate, a timely filing rejection, or a hospital that refuses the invoice. Underpayments against contracted rates appeared on 7.8% of paid claims in our audit work, and the average underpaid claim was short by $38.
CMS defines an independent laboratory as one independent of both a physician office and a hospital. It bills the Part B contractor on the CMS-1500 or 837P under its own NPI, place of service 81, paid on the Clinical Laboratory Fee Schedule. Its CLIA number goes in item 23 on paper and loop 2300 REF02 electronically, with the reference laboratory CLIA number in loop 2400 REF02.
A hospital laboratory testing a specimen from someone who is neither an inpatient nor a registered outpatient is doing non-patient work. Those claims go to the Part A contractor on bill type 14X using the UB-04 or 837I, paid on the laboratory fee schedule with no deductible and no coinsurance. The same hospital bills registered outpatient tests a different way entirely, which is why outreach revenue so often posts against the wrong contract.
A physician office laboratory bills under the practice billing NPI and must hold a certificate matched to what it runs: a Certificate of Waiver with QW on every waived code, or a Provider-Performed Microscopy certificate for moderate complexity microscopy performed during the visit. Claims from a laboratory out of compliance are denied.
Three business models, three claim forms, two Medicare contractors. A generalist team that treats a laboratory as one thing will bill an outreach program on a CMS-1500 and spend six months asking why nothing paid. In Massachusetts, radiology, pathology and independent labs generated 39.4% of state prior authorization volume in 2024, so the model also decides how much eligibility and prior authorization work sits in front of every claim. Detail on the Massachusetts medical billing page.
Chapter 16 section 40.1.1 of the Medicare Claims Processing Manual returns a referred-service claim without modifier 90 as unprocessable. Those claims carry no denial reason code, so they are never worked. Modifier 90 was missing on 12% of referred laboratory claims.
Chapter X of the NCCI Policy Manual states repeat testing cannot be billed to confirm initial results, or because of testing problems with specimens or equipment, when one reportable result is all that is required. Repeat test modifier errors appeared on 8% of same-day laboratory claims.
42 CFR 414.510(a) sets the date of service as the date the specimen was collected. Getting this wrong on a stored or hospital-referred specimen produces duplicates and timely filing rejections rather than an appealable denial.
CMS edits at the certificate level, so a waived-only laboratory billing a moderate or high complexity test is denied, not reduced. The five certificate types and the CLIA number requirement are in the CMS CLIA booklet. Laboratory claims rejected for a CLIA number problem carried a $63 median allowed value.
CMS accepts a signed order, an unsigned order plus an authenticated record showing intent, or an authenticated record documenting intent. It does not accept an attestation statement to rescue an unsigned order or an unsigned requisition, and signature stamps are prohibited except in narrow cases. See MLN909221. Ordering provider NPI was missing or invalid on 9% of lab claims.
We run the revenue cycle from eligibility to zero balance inside the practice management system you already use. How full-service billing works.
Certified coders review charges against your documentation and payer rules before the claim goes out, so the denial is prevented rather than appealed. Medical coding.
Aged and denied claims are worked to resolution, then the upstream cause is fixed so the same claims stop coming back. Denials and AR recovery.
Benefits are verified and authorizations secured before the appointment, which is the cheapest place in the cycle to stop a denial. Eligibility and prior authorization.
Statements, balance questions and payment plans are handled by the same team that worked the claim. Patient billing.
Payer enrollment and re-credentialing are tracked through to approval, so a lapsed credential never quietly stops payment. Credentialing.
A HIPAA-trained front-office assistant working inside your EHR on calls, scheduling, intake and referrals, alongside the billing team. Medical virtual assistant.
Laboratories do not switch systems to change billers, and we do not ask. We work inside the laboratory information system you already run: Sunquest, Epic Beaker, Oracle Health, Orchard Harvest, Clinisys, SCC SoftLab, CGM LABDAQ and Meditech, plus anatomic pathology and molecular reporting modules alongside them. On the practice management and claim side we work in athenahealth, eClinicalWorks, AdvancedMD, Kareo and whichever clearinghouse your 837 already goes through.
What we usually add is not software. It is the HL7 interface reconciliation between accessioned specimens, released results and generated charges, so a completed test cannot quietly finish without a claim behind it. Full service medical billing runs in your system, under your login trail, with a BAA signed before anybody gets access.
2 weeks
from a signed BAA to our team working your claims
About 3 weeks
to the first recovered payments on aged AR
20+ years
combined billing and coding experience
Orders, specimen accessions, and diagnosis information were reaching billing through different feeds. Luxen created a three-way match, reduced incomplete laboratory claims from 17% to 4%, and recovered $88,900.
Laboratory Director, regional clinical laboratory
Our team appealed medical-necessity denials one at a time without identifying the tests and payers driving them. Luxen grouped the patterns, cut repeat denials by 63%, and reduced the appeal backlog from 742 claims to 119.
Revenue Cycle Manager, independent diagnostic laboratory
Full engagements are written up in our dental practice case study and our ambulance billing case study.
Clinical diagnostic laboratory tests are not paid on the physician fee schedule. They are paid on the Clinical Laboratory Fee Schedule, where the rate equals the weighted median of private payer rates reported by applicable laboratories under section 216 of the Protecting Access to Medicare Act. The CY2026 annual update took effect January 1, 2026 under CR 14312, with a 1.9% update for services still paid on reasonable charge and a $18.54 national minimum for a Pap smear.
The Consolidated Appropriations Act, 2026, Public Law 119-75, enacted February 3, 2026, moved the reporting period to May 1 through July 31, 2026 on a data collection period of January 1 through June 30, 2025. The statutory payment reduction is 0% for 2026. Rates may then be cut by no more than 15% per year from 2027 through 2029. If your laboratory is an applicable laboratory, what you reported this summer sets what you are paid for the next three years.
Median days in AR dropped from 54 to 33 within 120 days across our client practices, and net collection rate rose from 91.4% to 97.8% over the first six months. In our billing reviews, 27% of total AR sat past 90 days in the average practice, 19% of denied claims were never reworked or appealed, and every 10 days removed from AR released a median $41,000 in cash. Where a large share of the book is toxicology panels ordered alongside behavioral health visits, as in West Virginia, reconciling the visit, the order and the panel is the whole job.
3% to 6% of collections
Luxen's pricing generally falls between 3% and 6% of collections, depending on claim volume, specialty, payer mix, and how much of the revenue cycle your practice hands over.
Higher-volume practices usually land toward the lower end. Smaller or more complex practices land higher because there is more work per account. There is no setup fee and no exit fee, and the agreement runs month to month with 30 days notice.
A lower fee attached to weak billing is still expensive. The number that matters is what your collections do after you hire someone.
Luxen charges 3% to 6% of collections. Laboratories sit in the lower half of that range because the claims are small and repetitive, higher where molecular registration or toxicology authorization is involved. Take an independent lab collecting $2,400,000 a year on roughly 46,000 claims, about $52 a claim.
| Annual line | In-house team | Luxen at 4.5% |
|---|---|---|
| Billing and coding staff | $148,000 | Included |
| AR and denial follow-up | $41,600 | Included |
| Fee on $2,400,000 collected | None | $108,000 |
| Total annual cost | $189,600 | $108,000 |
| Share of collections | 7.9% | 4.5% |
Fully loaded in-house billing cost 7.9% of collections for practices under $2M in our billing reviews, across 96 practices that shared payroll data. On $2,400,000 that is $189,600 against $108,000 at 4.5%, a difference of $81,600 a year before a single denial is worked.
The larger number is on the collection side. At a 91.4% net collection rate, $2,400,000 collected implies about $2,626,000 allowed. Net collection rate rose from 91.4% to 97.8% over the first six months across our client practices, which on the same allowed amount is about $2,568,000 collected, roughly $168,000 more. That is why we price on collections rather than per claim: per-claim pricing pays the same whether the claim is paid or written off. Patient balances are priced inside the same fee. See patient billing.
| Partner type | Good at | Where it fails a laboratory |
|---|---|---|
| In-house team | Control, direct access to accessioning staff | Costs 7.9% of collections at small scale, and one resignation stops denial work |
| Generalist billing company | Volume processing, low headline rate | Bills outreach on a CMS-1500, misses modifier 90, has never registered a molecular test |
| Specialty laboratory billing company | Knows CLFS, CLIA edits and MolDX | Usually moves you onto its own platform and prices every claim as if it were molecular |
| LIS or EHR vendor RCM | Native to the system you already run | Ties billing to a software contract, with whatever denial reporting the product ships |
| Luxen | Certified coders inside your existing LIS and PM, month to month | We do not sell software, so a laboratory wanting one vendor for both needs two |
In our survey, 44% could not name the fee basis in their current billing contract and 42% of practice managers said nobody owns denial follow-up full time. Ask for both in writing. If you are shortlisting, compare medical billing companies by state first, and check credentialing ownership separately, because a laboratory adding a new pathologist stops getting paid the moment enrollment lapses.
A 30-minute look at your AR ageing, denial reasons and payer mix. You leave knowing what is recoverable, what we would work first and what it would cost.
We sign a business associate agreement before anyone touches your system. Your named team then works inside the practice management system and clearinghouse you already use. Nothing is migrated, and claims are being worked within two weeks of the signed BAA.
Aged and denied claims come first because that is revenue you have already earned. Most practices see the first recovered payments inside three weeks.
Once the backlog is moving, we take over the agreed part of the daily cycle: eligibility, coding review, submission, posting, denials and patient balances.
You know who owns your claims. The team works inside the practice management system and EHR you already run, with no migration.
Claims are coded by certified coders against your documentation and payer rules. Automation handles the repetitive checks so people spend their time on the claims that need judgment.
We sign a business associate agreement before accessing protected health information, and access is limited to the named people on your account.
We look at your AR ageing, volume, payer mix and denial profile first, then tell you what we believe is recoverable and what it would cost.
A billing company is a poor fit if you are not willing to share visibility into your billing, if the vendor uses a rotating pool of people who never learn your practice, or if it cannot explain why your claims are being denied. Be wary of anyone promising large collection increases before they have seen your AR ageing. The right partner makes your revenue cycle more visible, not less.
A physician order creates an accession, the accession creates a charge, and the charge becomes a claim carrying your CLIA number, the ordering provider NPI and a diagnosis that has to satisfy a national coverage determination such as NCD 190.23 for lipid testing. Medicare pays clinical diagnostic tests on the Clinical Laboratory Fee Schedule, not the physician fee schedule, with no deductible and no coinsurance on assigned claims.
Luxen charges 3% to 6% of collections, month to month, with 30 days notice and no setup or exit fee. Most clinical laboratories land in the lower half of that range; molecular and toxicology work sits higher. For comparison, fully loaded in-house billing cost 7.9% of collections across 96 practices that shared payroll data with us.
About two weeks from signed BAA to working claims, and first recovered payments in about three weeks. Median time from signed BAA to first claims worked was 9 business days across our client practices. We work the oldest recoverable money first, because timely filing is the one deadline no appeal fixes.
No. We work inside Sunquest, Epic Beaker, Oracle Health, Orchard Harvest, Clinisys, SCC SoftLab, CGM LABDAQ, Meditech and whatever practice management system already produces your 837. There is no migration and no data conversion. In our practice manager survey, 38% had changed system in the past five years and 71% of those said collections dipped for at least six months afterwards.
Under 42 CFR 414.510 the date of service is normally the collection date, which means the hospital bills. The 14-day rule in 414.510(b)(2)(i) and the outpatient exception in 414.510(b)(5) let the performing laboratory bill Medicare directly for molecular pathology tests, advanced diagnostic laboratory tests, cancer-related protein-based tests and CPT 81490 when the stated conditions are met.
Thirty minutes, no deck and no fee. We look at what is sitting past 90 days and where your denials cluster, and you leave knowing what is recoverable, what we would work first, and what it would cost.
Book a Billing Review%20(1).avif)
